non-oral contraceptive methods should be considered [1] Optimization strategy : Tirzepatide monotherapy should be optimized to the maximally tolerated dose with confirmed adherence before considering phentermine addition Cost considerations : Both medications can be expensive, particularly tirzepatide, which may limit accessibility Any decision to combine these medications should involve shared decision-making with written informed consent, thorough evaluation of the patient's medical history, current health status, weight loss goals, and potential contraindications
There are currently approximately 340 million people in the United States, and in 2023 alone, about 1.7% of those individuals received a prescription for semaglutide
Every patient is unique, so our team will assess your health history, weight loss goals, and overall suitability for these medications during your consultation
19 (See below for details of 2025 state legislation on this issue) It should also be noted that health plans are always free to offer coverage that goes above and beyond the EHB benchmark plan
Another factor is the way tirzepatide affects reward-related eating